Pacific Heights Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21,000
| Closed | -$269K | – | 73 |
|
|
2023
Q4 | $269K | Hold |
21,000
| – | – | 0.02% | 74 |
|
|
2023
Q3 | $777K | Hold |
21,000
| – | – | 0.07% | 73 |
|
|
2023
Q2 | $845K | Hold |
21,000
| – | – | 0.08% | 73 |
|
|
2023
Q1 | $1.52M | Hold |
21,000
| – | – | 0.14% | 75 |
|
|
2022
Q4 | $1.72M | Hold |
21,000
| – | – | 0.17% | 75 |
|
|
2022
Q3 | $1.98M | Hold |
21,000
| – | – | 0.21% | 78 |
|
|
2022
Q2 | $4.09M | Hold |
21,000
| – | – | 0.42% | 71 |
|
|
2022
Q1 | $4.88M | Hold |
21,000
| – | – | 0.42% | 70 |
|
|
2021
Q4 | $8.27M | Hold |
21,000
| – | – | 0.7% | 50 |
|
|
2021
Q3 | $9.4M | Hold |
21,000
| – | – | 0.89% | 44 |
|
|
2021
Q2 | $8.16M | Buy |
21,000
+4,000
| +24% | +$1.56M | 0.75% | 47 |
|
|
2021
Q1 | $6.1M | Buy |
17,000
+6,000
| +55% | +$2.15M | 0.56% | 57 |
|
|
2020
Q4 | $5.4M | Hold |
11,000
| – | – | 0.53% | 58 |
|
|
2020
Q3 | $3.56M | Hold |
11,000
| – | – | 0.46% | 59 |
|
|
2020
Q2 | $4.01M | Buy |
11,000
+880
| +9% | +$321K | 0.6% | 52 |
|
|
2020
Q1 | $2.84M | Buy |
10,120
+3,120
| +45% | +$875K | 0.48% | 61 |
|
|
2019
Q4 | $2.88M | Hold |
7,000
| – | – | 0.36% | 69 |
|
|
2019
Q3 | $2.47M | Hold |
7,000
| – | – | 0.33% | 70 |
|
|
2019
Q2 | $3.52M | Hold |
7,000
| – | – | 0.46% | 66 |
|
|
2019
Q1 | $6.96M | Buy |
7,000
+2,000
| +40% | +$1.99M | 0.91% | 38 |
|
|
2018
Q4 | $4.34M | Hold |
5,000
| – | – | 0.59% | 57 |
|
|
2018
Q3 | $5.17M | Hold |
5,000
| – | – | 0.57% | 61 |
|
|
2018
Q2 | $4.59M | Hold |
5,000
| – | – | 0.47% | 64 |
|
|
2018
Q1 | $4.88M | Buy |
5,000
+4,000
| +400% | +$3.9M | 0.52% | 62 |
|
|
2017
Q4 | $453K | Buy |
+1,000
| New | +$453K | 0.04% | 74 |
|